The cattle gastrointestinal infection treatment market is projected to grow from USD 2.3 billion in 2026 to USD 4.6 billion by 2036, at a CAGR of 7.2%. Antibiotics will dominate with a 38.0% market share, while bacterial gi infections will lead the applications segment with a 42.0% share.